CICON16: Cancer Antigens and the Development of Personalized Immunotherapy Approaches September 26, 2016December 14, 2022 Arthur N. Brodsky, PhD
CICON16: Beyond PD-1 and CTLA-4: The New Checkpoints September 26, 2016December 14, 2022 Arthur N. Brodsky, PhD